Last reviewed · How we verify

Myelofibrosis (MF) in adult patients who are refractory or resistant to other therapies

12 treatments

Approved treatments

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Frequently asked questions about Myelofibrosis (MF) in adult patients who are refractory or resistant to other therapies

What drugs treat Myelofibrosis (MF) in adult patients who are refractory or resistant to other therapies?

Tracked treatments include 6-tioguanine+Standard Maintenance Therapy.

What is the treatment for Myelofibrosis (MF) in adult patients who are refractory or resistant to other therapies?

Standard treatment for Myelofibrosis (MF) in adult patients who are refractory or resistant to other therapies includes 6-tioguanine+Standard Maintenance Therapy. See the treatment landscape page for first-line, second-line and salvage options.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing